In a new study entitled “Subclinical atherosclerosis and peripheral vascular disease in systemic sclerosis patients: Relation to potential risk factors,” authors suggest that patients with Systemic sclerosis may have increased risk of developing subclinical atherosclerotic macro vascular disease. The team highlights that further research is necessary to tackle both…
News
A new clinical trial on Systemic Sclerosis (also known as Scleroderma) is now recruiting participants – adult patients (at least 18 years old) with a confirmed diagnosis of systemic sclerosis (SSc), as defined by the American College of Rheumatology criteria — who are willing to participate (the study…
In a recent study published in the journal Arthritis Research & Therapy, a research team from the Yonsei University College of Medicine in Seoul, South Korea found that patients with Raynaud’s phenomenon (RP) met 2013 American College of Rheumatology/European League Against Rheumatism criteria for systemic sclerosis…
The European Commission has granted late stage cell therapy company Cytori Therapeutics, Inc.’s ECCS-50 cellular therapy the designation of orphan medicinal product for the treatment of scleroderma. The decision, which was made due to positive references from the European Medicines Agency’s (EMA) Committee for Orphan Medicinal Products, represents the first time an…
A study recently published in the on-line journal Clinical and Experimental Rheumatology is challenging the clinical assumptions that morphea and systemic sclerosis (SSc) should be considered the part of the same disease spectrum. The study, entitled, “Prospective evaluation of frequency of signs of systemic sclerosis…
Results from a recent study published in the journal The Egyptian Rheumatologist provide new evidence of inner ear involvement in Systemic sclerosis (SSc) causing audiovestibular abnormalities. Systemic sclerosis (SSc) is an autoimmune connective tissue disease characterized by fibrosis mainly in the skin, vasculopathy with…
A recent Case Report entitled “Posterior Reversible Encephalopathy Syndrome as Presenting Form of Very Early Systemic Sclerosis,” describes a rare case of a patient with Posterior Reversible Encephalopathy Syndrome (PRES) caused by arterial hypertension and very early systemic sclerosis (SSc). The report is published in…
Researchers at Centro Universitário Augusto Motta and Hospital Federal de Bonsucesso in Rio de Janeiro, Brazil recently discovered that muscle strength in the lower limbs of patients with systemic sclerosis influences the patient’s functional capacity and quality of life. The study is entitled “Lower…
Researchers from the University of Cologne in Germany showed that Systemic sclerosis-overlap Syndrome should be regarded as different separate subset in Systemic sclerosis (SSc) patients. The study entitled “Disease progression in systemic sclerosis-overlap syndrome is significantly different from limited and diffuse cutaneous systemic sclerosis” appeared on…
A recent study published in the journal PLOS One reports the results of a comprehensive clinical assessment review in patients with Systemic sclerosis and lung cancer. Systemic sclerosis (SSc) is a connective tissue disorder characterized by immune dysregulation and accumulation of extracellular matrix constituents resulting in…
Recent Posts
- Cosmetic laser therapy could be repurposed for localized scleroderma
- Antibody levels may help reflect quality of life in people with scleroderma
- Certain antibodies tied to poorer outcomes in systemic sclerosis
- Dexamethasone reduces inflammation, scarring in SSc mouse model: Study
- Survival improves for SSc-PAH patients on combination therapy
- Combination drug therapy boosts lung, skin health in SSc patients
- On choosing medicine’s side effects over scleroderma progression
- Telerehabilitation improves hand mobility in scleroderma women
- Molecular pathway ID’d as key driver of scarring in scleroderma
- Limited hand function disrupts daily life for people living with SSc